CRSP
CRISPR Therapeutics AG
Stock
$55.43−0.01 (−0.02%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$345M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$345M | — |
| 2024 | −$143M | — |
| 2023 | −$260M | — |
| 2022 | −$496M | — |
| 2021 | $539M | — |
| 2020 | −$238M | — |
| 2019 | $57M | — |
| 2018 | −$96M | — |
| 2017 | −$70M | — |
| 2016 | −$53M | — |
| 2015 | $59M | — |
| 2014 | −$4.8M | — |